References
- Donato CM, Ch’ng LS, Boniface KF et al. Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination. J. Infect. Dis. 206(3), 377–383 (2012).
- Ramig RF. Genetics of the rotaviruses. Annu. Rev. Microbiol. 51, 225–255 (1997).
- Angel J, Franco MA, Greenberg HB. Rotavirus vaccines: recent developments and future considerations. Nat. Rev. Microbiol. 5(7), 529–539 (2007).
- Matthijnssens J, Joelsson DB, Warakomski DJ et al. Molecular and biological characterization of the 5 human–bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 403(2), 111–127 (2010).
- Yen C, Jakob K, Esona MD et al. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine 29(24), 4151–4155 (2011).
- RotaTeq®, package insert: Merck, US Department of Health and Human Services, FDA, Center for Biologics Evaluation and Research, MD, USA.
- Clark HF, Bernstein DI, Dennehy PH et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human–bovine reassortant rotavirus vaccine in healthy infants. J. Pediatr. 144(2), 184–190 (2004).
- Payne DC, Edwards KM, Bowen MD et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics 125(2), e438–e441 (2010).
- Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect. Dis. 8(10), 642–649 (2008).
- Hemming M, Vesikari T. Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis. Pediatr. Infect. Dis. J. 31(9), 992–994 (2012).
- Bucardo F, Rippinger CM, Svensson L, Patton JT. Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. Infect. Genet. Evol. 12(6), 1282–1294 (2012).
- Cortese MM, Parashar UD; Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 58(RR-2), 1–25 (2009).
- Pérez-Schael I, Guntiñas MJ, Pérez M et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N. Engl. J. Med. 337(17), 1181–1187 (1997).
- Alexander LN, Seward JF, Santibanez TA et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA 292(14), 1696–1701 (2004).
- Rivera L, Peña LM, Stainier I et al. Horizontal transmission of a human rotavirus vaccine strain – a randomized, placebo-controlled study in twins. Vaccine 29(51), 9508–9513 (2011).
- Patel NC, Hertel PM, Estes MK et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N. Engl. J. Med. 362(4), 314–319 (2010).
- Uygungil B, Bleesing JJ, Risma KA, McNeal MM, Rothenberg ME. Persistent rotavirus vaccine shedding in a new case of severe combined immunodeficiency: a reason to screen. J. Allergy Clin. Immunol. 125(1), 270–271 (2010).
- Centers for Disease Control and Prevention. Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine. MMWR Morb. Mortal. Wkly Rep. 59(22), 687–688 (2010).
- Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 126(3), e506–e512 (2010).